Millions of unborn Americans have died from the abortion pill, which since 2021 has been sent through the mails to virtually anyone who requests it online.
We were promised almost two years ago that the FDA would review the Biden-era decision that ended the in-person dispensing requirement. That review has not yet been announced; some suspect it has not even begun.
The evidence suggests that certain political types in the White House — including recently departed chief of staff Susie Wiles — may have had a hand in this because they did not want abortion to become an election issue.
Whatever the cause of the delay, the midterms are over, and it’s time for the FDA to act.
As far as a review is concerned, all the FDA has to do is read a new peer-reviewed study by the Charlotte Lozier Institute. This leaves no doubt that the Biden-era decision was based on faulty evidence and should be overturned.
The authors, Dr. Ingrid Skop and Dr. Zachary Sluzala, found that the FDA admitted it had no proof that the abortion pill could be safety distributed by mail, but it went ahead and recklessly approved it anyway.
The Biden FDA claimed to be following the evidence when it ended the in-person dispensing requirement for mifepristone in 2021. It cited published studies, outside experts, and its own adverse event records, and concluded that the abortion pill could be safely prescribed online and sent through the mail.
But Skop and Sluzala show that none of these earlier studies actually addressed the safety concerns raised by abortion-by-mail, much less by the deadly drug itself.
How could they? Nearly all of women in the studies had seen a doctor before the abortion and/or had followed up with one afterward. Most had been given either ultrasounds or blood work, and follow-up pelvic examinations.
In other words, they were under the continuing care of a provider.
That is not how chemical abortion works today. Most women never see a provider; they simply fill out an online form. There is no ultrasound and no follow-up visit.
Studies of women who took the abortion pill under medical supervision tell us nothing about the fate of women taking the pill on their own today.
The lack of an ultrasound in the current abortion-by-mail regimen is a major problem.
Without an ultrasound, it is difficult to judge how far along in pregnancy a woman is. Many women can’t remember the date of their last cycle or have irregular cycles. Some may have conceived while using some form of contraception or simply have been in denial for several months.
There’s a good reason for the FDA’s 70-day limit on taking the abortion pill. After that point the risk of failed abortions, surgery to complete them, and infections skyrockets.
Without an ultrasound, there is no way to know if the woman is having ectopic pregnancy, in which the child implants somewhere outside the womb, usually in a fallopian tube. The abortion pill will not end such a pregnancy, but the cramping and bleeding that accompanies it may mask the rupture of a fallopian tube. This is a life-threatening emergency, but by the time a woman realizes something is wrong she may already be dying.
Another problem that has arisen with abortion-by-mail is that women (or their boyfriends) are stockpiling abortion pills before they are even pregnant. One online prescriber, called Aid Access, received 48,404 such requests between September 2021 and April 2023. No one — certainly not the FDA — knows how many of those pills were taken, how late in pregnancy they were taken, and how many women were injured or killed as a result.
If the FDA played fast and loose with these earlier abortion pill studies, it was equally uncritical where the submissions of outside abortion-minded groups were concerned.
The National Abortion Federation, the American College of Obstetricians and Gynecologists, and the Society of Family Planning all sent in statements supporting the removal of in-person dispensing. All were immediately accepted and carefully reviewed.
But when the American Association of Pro-Life Obstetricians and Gynecologists and the American College of Pediatricians sent in statements cautioning that dropping the safeguards would put women at risk, they received no response from the FDA. The FDA sat on their submissions for months — and only sent out letters of rejection on the very day that it publicized its decision. The Biden FDA wanted to make sure that dissenting pro-life voices were silenced, and it did.
The Biden FDA also played games with the so-called “adverse event” numbers — the numbers of women who were reportedly harmed in one way or another by the abortion pill.
Back in 2016, the FDA had stopped requiring providers to report nonfatal complications to the companies making the abortion pill. Then it turned around in 2021 and pointed to the small number of reports — only 55 to the companies and eight to the FDA itself – -as proof that the drug was safe.
But the FDA itself had made the reporting voluntary. A low count only shows that providers were not taking the time to report complications among their patients, not that their patients were not being harmed.
Then there are the emergency room records that the Biden FDA cited to prove the “safety” of the abortion pill; these are equally misleading. Some abortion providers tell women not to mention the abortion pill if they have to go to the ER but to simply say they are having a miscarriage. One study found that more than 80 percent of ER visits for chemical abortion complications were wrongly coded as miscarriages.
The Biden FDA actually admitted that it could not determine the safest method of distributing the abortion pill. That alone should have kept the in-person requirement in place, but the agency removed it instead.
In my view, Biden’s FDA was determined to flood America with abortion pills regardless of the harm that this might cause to women (not to mention their unborn children). That’s why it used studies of women under a doctor’s care to approve a system with no care at all, only accepted submissions from pro-abortion groups, and relied on data on side effects that its own actions had ensured would be a gross underestimate of the actual suffering and deaths caused by the abortion pill.
The promised review of the abortion pill can and should correct this harmful decision.
With the appointment of a new presidential chief of staff Stephen Miller, I am hopeful this review will be completed soon.
As Robert F. Kennedy Jr. just posted, “Next to me, Stephen Miller is the strongest MAHA supporter in the administration. It’s time to unleash the Kraken.”
******
This article originally appeared on LifeSite News.





